Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Carter

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Conservation Biology : the Journal of the Society for Conservation Biology|January 17, 2017
International consensus principles for ethical wildlife controlSara Dubois, Nicole Fenwick, Erin A Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancerDariush Etemadmoghadam, George Au-Yeung, Meaghan Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2016
Landscape of Genomic Alterations in Pituitary AdenomasWenya Linda Bi, Peleg Horowitz, Noah F Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell CarcinomaKent W Mouw, James M Cleary, Brendan Reardon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 6, 2009
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157Joanna S Fowler, Jean Logan, Albert J Azzaro, et al.
Blood Advances|February 7, 2019
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2023
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain MetastasesSarah Jenkins, Wei Zhang, Seth M Steinberg, et al.
The New England Journal of Medicine|June 11, 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, Daniel J Brat, Roel G W Verhaak, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Conservation Biology : the Journal of the Society for Conservation Biology|January 17, 2017
International consensus principles for ethical wildlife controlSara Dubois, Nicole Fenwick, Erin A Ryan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2013
Resistance to CDK2 inhibitors is associated with selection of polyploid cells in CCNE1-amplified ovarian cancerDariush Etemadmoghadam, George Au-Yeung, Meaghan Wall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2016
Landscape of Genomic Alterations in Pituitary AdenomasWenya Linda Bi, Peleg Horowitz, Noah F Greenwald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2016
Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell CarcinomaKent W Mouw, James M Cleary, Brendan Reardon, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 6, 2009
Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157Joanna S Fowler, Jean Logan, Albert J Azzaro, et al.
Blood Advances|February 7, 2019
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2023
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain MetastasesSarah Jenkins, Wei Zhang, Seth M Steinberg, et al.
The New England Journal of Medicine|June 11, 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas, Daniel J Brat, Roel G W Verhaak, et al.
Pageof 3